Targeted multimodal imaging modalities

Advanced Drug Delivery Reviews

Volumn 76, Issue 1, 2014, Pages 60-78

  Lee, Seung Yong ^a   Jeon, Seong Ik ^a   Jung, Seulhee ^a   Chung, In Jae ^a   Ahn, Cheol Hee ^a  

^a Seoul National University   (South Korea)

Author keywords

Active targeting; Imaging probes; Molecular imaging; Multimodality; Targeting moieties

Indexed keywords

BIOLOGY; DIAGNOSIS; PROBES;

ACTIVE TARGETING; BIOLOGICAL INFORMATION; CLINICAL DIAGNOSTIC IMAGING; HIGH SPATIAL RESOLUTION; IMAGING PROBE; MULTI-MODALITY; MULTIMODAL IMAGING AGENTS; TARGETING MOIETIES;

MOLECULAR IMAGING;

ARGINYLGLUTAMYLLYSYLALANINE; ARGINYLGLYCYLASPARTIC ACID; FOLIC ACID; GLUTAMYLPROPYLPROPYLTHREONINE; NANOPARTICLE; OLEANOLIC ACID; PEPTIDE; POLYACRYLIC ACID; TRASTUZUMAB; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FLUORESCENCE IMAGING; HUMAN; MOLECULAR IMAGING; MULTIMODAL IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOACOUSTICS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; PROCEDURES;

ANIMALS; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84922061723     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2014.07.009     Document Type: Review

References (141)

1. Cherry S.R. In vivo molecular and genomic imaging: new challenges for imaging physics. Phys. Med. Biol. 2004, 49:R13.
2. Cheon J., Lee J.-H. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc. Chem. Res. 2008, 41:1630-1640.
3. Townsend D.W., Cherry S.R. Combining anatomy and function: the path to true image fusion. Eur. Radiol. 2001, 11:1968-1974.
4. Zhu D., Liu F., Ma L., Liu D., Wang Z. Nanoparticle-based systems for T1-weighted magnetic resonance imaging contrast agents. Int. J. Mol. Sci. 2013, 14:10591-10607.
5. Fani M., Maecke H., Okarvi S. Radiolabeled peptides: valuable tools for the detection and treatment of cancer. Theranostics 2012, 2:481.
6. Lee N., Choi S.H., Hyeon T. Nano-sized CT contrast agents. Adv. Mater. 2013, 25:2641-2660.
7. Garcia E.V. Physical attributes, limitations, and future potential for PET and SPECT. J. Nucl. Cardiol. 2012, 19:S19-S29.
8. Jennings L.E., Long N.J. 'Two is better than one'-probes for dual-modality molecular imaging. Chem. Commun. 2009, 3511-3524.
9. Ell P. The contribution of PET/CT to improved patient management. Br. J. Radiol. 2006, 79:32-36.
10. Tsukamoto E., Ochi S. PET/CT today: system and its impact on cancer diagnosis. Ann. Nucl. Med. 2006, 20:255-267.
11. Sirlin C.B., Vera D.R., Corbeil J.A., Caballero M.B., Buxton R.B., Mattrey R.F. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. Acad. Radiol. 2004, 11:1361-1369.
12. Lee N., Hyeon T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem. Soc. Rev. 2012, 41:2575-2589.
13. Iyer A.K., Khaled G., Fang J., Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 2006, 11:812-818.
14. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 2000, 65:271-284.
15. Byrne J.D., Betancourt T., Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 2008, 60:1615-1626.
16. Veiseh O., Gunn J.W., Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 2010, 62:284-304.
17. Rosen J.E., Chan L., Shieh D.-B., Gu F.X. Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine: NBM 2012, 8:275-290.
18. Yu M.K., Park J., Jon S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2012, 2:3.
19. Haun J.B., Devaraj N.K., Hilderbrand S.A., Lee H., Weissleder R. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. Nat. Nanotechnol. 2010, 5:660-665.
20. Marks J.D. Selection of internalizing antibodies for drug delivery. Antibody Engineering 2004, 201-208. Springer.
21. Marks J.D., Ouwehand W.H., Bye J.M., Finnern R., Gorick B.D., Voak D., Thorpe S., Hughes-Jones N.C., Winter G. Human antibody fragments specific for human blood group antigens from a phage display library. Nat. Biotechnol. 1993, 11:1145-1149.
22. Yu Y.P., Wang Q., Liu Y.C., Xie Y. Molecular basis for the targeted binding of RGD-containing peptide to integrin alpha(V)beta(3). Biomaterials 2014, 35:1667-1675.
23. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
24. Gardner M.J., Catterall J.B., Jones L.M.H., Turner G.A. Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis. Clin. Exp. Metastasis 1996, 14:325-334.
25. 4 nanocrystals. Nanoscale Res. Lett. 2013, 8:1-9.
26. Kim J., Piao Y., Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem. Soc. Rev. 2009, 38:372-390.
27. 4) nanoparticles in a silica shell. Macromol. Biosci. 2013, 13:321-331.
28. Ogawa M., Regino C.A.S., Seidel J., Green M.V., Xi W., Williams M., Kosaka N., Choyke P.L., Kobayashi H. Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection. Bioconjug. Chem. 2009, 20:2177-2184.
29. Lee H.-Y., Li Z., Chen K., Hsu A.R., Xu C., Xie J., Sun S., Chen X. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J. Nucl. Med. 2008, 49:1371-1379.
30. Rolfe B.E., Blakey I., Squires O., Peng H., Boase N.R.B., Alexander C., Parsons P.G., Boyle G.M., Whittaker A.K., Thurecht K.J. Multi-modal polymer nanoparticles with combined 19F magnetic resonance and optical detection for tunable, targeted, multimodal imaging in vivo. J. Am. Chem. Soc. 2014, 136(6):2413-2419.
31. Kim S.-m., Chae M.K., Yim M.S., Jeong I.H., Cho J., Lee C., Ryu E.K. Hybrid PET/MR imaging of tumors using an oleanolic acid-conjugated nanoparticle. Biomaterials 2013, 34:8114-8121.
32. Lin X., Xie J., Niu G., Zhang F., Gao H., Yang M., Quan Q., Aronova M.A., Zhang G., Lee S., Leapman R., Chen X. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett. 2011, 11:814-819.
33. Kimura R.H., Miao Z., Cheng Z., Gambhir S.S., Cochran J.R. A dual-labeled knottin peptide for pET and near-infrared fluorescence imaging of integrin expression in living subjects. Bioconjug. Chem. 2010, 21:436-444.
34. Lee J.-H., Lee K., Moon S.H., Lee Y., Park T.G., Cheon J. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew. Chem. Int. Ed. 2009, 48:4174-4179.
35. Jo M.-h., Ali B.A., Al-Khedhairy A.A., Lee C.H., Kim B., Haam S., Huh Y.-M., Ko H.Y., Kim S. A reverse complementary multimodal imaging system to visualize microRNA9-involved neurogenesis using peptide targeting transferrin receptor-conjugated magnetic fluorescence nanoparticles. Biomaterials 2012, 33:6456-6467.
36. Basit L., Nepijko S.A., Shukoor I., Ksenofontov V., Klimenkov M., Fecher G.H., Schönhense G., Tremel W., Felser C. Structure and magnetic properties of iron-platinum particles with γ-ferric-oxide shell. Appl. Phys. A 2009, 94:619-625.
37. Huang J., Xie J., Chen K., Bu L., Lee S., Cheng Z., Li X., Chen X. HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging. Chem. Commun. 2010, 46:6684-6686.
38. An K., Kwon S.G., Park M., Na H.B., Baik S.-I., Yu J.H., Kim D., Son J.S., Kim Y.W., Song I.C., Moon W.K., Park H.M., Hyeon T. Synthesis of uniform hollow oxide nanoparticles through nanoscale acid etching. Nano Lett. 2008, 8:4252-4258.
39. 2 core/shell nanocomposites. ACS Nano 2011, 5:4177-4187.
40. Pan D., Caruthers S.D., Hu G., Senpan A., Scott M.J., Gaffney P.J., Wickline S.A., Lanza G.M. Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets. J. Am. Chem. Soc. 2008, 130:9186-9187.
41. Serda R.E., Godin B., Blanco E., Chiappini C., Ferrari M. Multi-stage delivery nano-particle systems for therapeutic applications. Biochim. Biophys. Acta, Gen. Subj. 2011, 1810:317-329.
42. Thorek D.J., Chen A., Czupryna J., Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann. Biomed. Eng. 2006, 34:23-38.
43. Lee D.-E., Koo H., Sun I.-C., Ryu J.H., Kim K., Kwon I.C. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem. Soc. Rev. 2012, 41:2656-2672.
44. Sun Y., Zhu X., Peng J., Li F. Core-shell lanthanide upconversion nanophosphors as four-modal probes for tumor angiogenesis imaging. ACS Nano 2013, 7:11290-11300.
45. Chen W., Jarzyna P.A., van Tilborg G.A.F., Nguyen V.A., Cormode D.P., Klink A., Griffioen A.W., Randolph G.J., Fisher E.A., Mulder W.J.M., Fayad Z.A. RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe. FASEB J. 2010, 24:1689-1699.
46. Nam T., Park S., Lee S.-Y., Park K., Choi K., Song I.C., Han M.H., Leary J.J., Yuk S.A., Kwon I.C., Kim K., Jeong S.Y. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging. Bioconjug. Chem. 2010, 21:578-582.
47. 3-integrin targeted multimodal quantum dots. Angiogenesis 2009, 12:17-24.
48. Yan H., Wang L., Wang J., Weng X., Lei H., Wang X., Jiang L., Zhu J., Lu W., Wei X., Li C. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano 2011, 6:410-420.
49. Cheng L., Yang K., Li Y., Zeng X., Shao M., Lee S.-T., Liu Z. Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 2012, 33:2215-2222.
50. 3-targeted PAMAM dendrimers. Mol. Pharm. 2008, 5:527-539.
51. Yang X., Hong H., Grailer J.J., Rowland I.J., Javadi A., Hurley S.A., Xiao Y., Yang Y., Zhang Y., Nickles R.J., Cai W., Steeber D.A., Gong S. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 2011, 32:4151-4160.
52. Y. Song, Z. Huang, J. Xu, D. Ren, Y. Wang, X. Zheng, Y. Shen, L. Wang, H. Gao, J. Hou, Z. Pang, J. Qian, J. Ge, Multimodal SPION-CREKA peptide based agents for molecular imaging of microthrombus in a rat myocardial ischemia-reperfusion model, Biomaterials.
53. Kumar M., Yigit M., Dai G., Moore A., Medarova Z. Image-guided breast tumor therapy using a small interfering RNA nanodrug. Cancer Res. 2010, 70:7553-7561.
54. Medarova Z., Pham W., Kim Y., Dai G., Moore A. In vivo imaging of tumor response to therapy using a dual-modality imaging strategy. Int. J. Cancer 2006, 118:2796-2802.
55. Medarova Z., Rashkovetsky L., Pantazopoulos P., Moore A. Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging. Cancer Res. 2009, 69:1182-1189.
56. Moore A., Medarova Z., Potthast A., Dai G. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res. 2004, 64:1821-1827.
57. Veiseh O., Sun C., Gunn J., Kohler N., Gabikian P., Lee D., Bhattarai N., Ellenbogen R., Sze R., Hallahan A., Olson J., Zhang M. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett. 2005, 5:1003-1008.
58. Abou D., Thorek D.J., Ramos N., Pinkse M.H., Wolterbeek H., Carlin S., Beattie B., Lewis J. 89Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer. Pharm. Res. 2013, 30:878-888.
59. Lee J.-H., Huh Y.-M., Jun Y.-w., Seo J.-w., Jang J.-t., Song H.-T., Kim S., Cho E.-J., Yoon H.-G., Suh J.-S., Cheon J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 2007, 13:95-99.
60. Huh Y.-M., Jun Y.-w., Song H.-T., Kim S., Choi J.-s., Lee J.-H., Yoon S., Kim K.-S., Shin J.-S., Suh J.-S., Cheon J. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J. Am. Chem. Soc. 2005, 127:12387-12391.
61. Hwang D.W., Ko H.Y., Lee J.H., Kang H., Ryu S.H., Song I.C., Lee D.S., Kim S. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J. Nucl. Med. 2010, 51:98-105.
62. Tu C., Ng T.C., Jacobs R., Louie A. Multimodality PET/MRI agents targeted to activated macrophages. J. Biol. Inorg. Chem. 2014, 19:247-258.
63. Lee C.-M., Jeong H.-J., Kim E.-M., Kim D.W., Lim S.T., Kim H.T., Park I.-K., Jeong Y.Y., Kim J.W., Sohn M.-H. Superparamagnetic iron oxide nanoparticles as a dual imaging probe for targeting hepatocytes in vivo. Magn. Reson. Med. 2009, 62:1440-1446.
64. Das M., Bandyopadhyay D., Mishra D., Datir S., Dhak P., Jain S., Maiti T.K., Basak A., Pramanik P. "Clickable", trifunctional magnetite nanoparticles and their chemoselective biofunctionalization. Bioconjug. Chem. 2011, 22:1181-1193.
65. Mitra R.N., Doshi M., Zhang X., Tyus J.C., Bengtsson N., Fletcher S., Page B.D.G., Turkson J., Gesquiere A.J., Gunning P.T., Walter G.A., Santra S. An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery. Biomaterials 2012, 33:1500-1508.
66. Fan W., Shen B., Bu W., Chen F., Zhao K., Zhang S., Zhou L., Peng W., Xiao Q., Xing H., Liu J., Ni D., He Q., Shi J. Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging. J. Am. Chem. Soc. 2013, 135:6494-6503.
67. Kim J.S., Rieter W.J., Taylor K.M.L., An H., Lin W., Lin W. Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging. J. Am. Chem. Soc. 2007, 129:8962-8963.
68. Carlsson J., Nordgren H., Sjostrom J., Wester K., Villman K., Bengtsson N.O., Ostenstad B., Lundqvist H., Blomqvist C. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. Br. J. Cancer 2004, 90:2344-2348.
69. Bardhan R., Chen W., Perez-Torres C., Bartels M., Huschka R.M., Zhao L.L., Morosan E., Pautler R.G., Joshi A., Halas N.J. Nanoshells with targeted simultaneous enhancement of magnetic and optical imaging and photothermal therapeutic response. Adv. Funct. Mater. 2009, 19:3901-3909.
70. 2O nanomaterial as a potential T1 MRI-CT dual contrast agent. Eur. J. Inorg. Chem. 2013, 2013:2858-2866.
71. Mulder W.J.M., Koole R., Brandwijk R.J., Storm G., Chin P.T.K., Strijkers G.J., de Mello Donegá C., Nicolay K., Griffioen A.W. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett. 2005, 6:1-6.
72. Shukoor M.I., Natalio F., Tahir M.N., Wiens M., Tarantola M., Therese H.A., Barz M., Weber S., Terekhov M., Schröder H.C., Müller W.E.G., Janshoff A., Theato P., Zentel R., Schreiber L.M., Tremel W. Pathogen-mimicking MnO nanoparticles for selective activation of the TLR9 pathway and imaging of cancer cells. Adv. Funct. Mater. 2009, 19:3717-3725.
73. Jayapaul J., Hodenius M., Arns S., Lederle W., Lammers T., Comba P., Kiessling F., Gaetjens J. FMN-coated fluorescent iron oxide nanoparticles for RCP-mediated targeting and labeling of metabolically active cancer and endothelial cells. Biomaterials 2011, 32:5863-5871.
74. Uppal R., Catana C., Ay I., Benner T., Sorensen A.G., Caravan P. Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe-feasibility study in rat model. Radiology 2011, 258:812-820.
75. Jarrett B.R., Correa C., Ma K.L., Louie A.Y. In vivo mapping of vascular inflammation using multimodal imaging. PLoS ONE 2010, 5:e13254.
76. Zheng J., Allen C., Jaffray D., Chopra A. PEGylated liposome co-encapsulating iohexol and gadoteridol for multimodal CT and MR imaging. Molecular Imaging and Contrast Agent Database (MICAD), National Center for Biotechnology Information (US), Bethesda (MD) 2004.
77. Trubetskoy V.S., Gazelle G.S., Wolf G.L., Torchilin V.P. Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: design of long-circulating particulate contrast medium for X-ray computed tomography. J. Drug Target. 1997, 4:381-388.
78. Torchilin V.P., Frank-Kamenetsky M.D., Wolf G.L. CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles. Acad. Radiol. 1999, 6:61-65.
79. Narayanan S., Sathy B.N., Mony U., Koyakutty M., Nair S.V., Menon D. Biocompatible magnetite/gold nanohybrid contrast agents via green chemistry for MRI and CT bioimaging. ACS Appl. Mater. Interfaces 2011, 4:251-260.
80. Hu D.-H., Sheng Z.-H., Zhang P.-F., Yang D.-Z., Liu S.-H., Gong P., Gao D.-Y., Fang S.-T., Ma Y.-F., Cai L.-T. Hybrid gold-gadolinium nanoclusters for tumor-targeted NIRF/CT/MRI triple-modal imaging in vivo. Nanoscale 2013, 5:1624-1628.
81. Chou S.-W., Shau Y.-H., Wu P.-C., Yang Y.-S., Shieh D.-B., Chen C.-C. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. J. Am. Chem. Soc. 2010, 132:13270-13278.
82. Oh M.H., Lee N., Kim H., Park S.P., Piao Y., Lee J., Jun S.W., Moon W.K., Choi S.H., Hyeon T. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J. Am. Chem. Soc. 2011, 133:5508-5515.
83. Pan D., Roessl E., Schlomka J.P., Caruthers S.D., Senpan A., Scott M.J., Allen J.S., Zhang H., Hu G., Gaffney P.J., Choi E.T., Rasche V., Wickline S.A., Proksa R., Lanza G.M. Computed tomography in color: nanoK-enhanced spectral CT molecular imaging. Angew. Chem. Int. Ed. Engl. 2010, 49:9635-9639.
84. Cheung E.N.M., Alvares R.D.A., Oakden W., Chaudhary R., Hill M.L., Pichaandi J., Mo G.C.H., Yip C., Macdonald P.M., Stanisz G.J., van Veggel F.C.J.M., Prosser R.S. Polymer-stabilized lanthanide fluoride nanoparticle aggregates as contrast agents for magnetic resonance imaging and computed tomography. Chem. Mater. 2010, 22:4728-4739.
85. Tian M., Lu W., Zhang R., Xiong C., Ensor J., Nazario J., Jackson J., Shaw C., Dixon K., Miller J., Wright K., Li C., Gupta S. Tumor uptake of hollow gold nanospheres after intravenous and intra-arterial injection: PET/CT study in a rabbit VX2 liver cancer model. Mol. Imaging Biol. 2013, 15:614-624.
86. 4 core/Au shell nanoparticles for targeting and multimodal imaging of cancer cells. J. Mater. Chem. 2012, 22:470-477.
87. Menichetti L., Manzoni L., Paduano L., Flori A., Kusmic C., De Marchi D., Casciaro S., Conversano F., Lombardi M., Positano V., Arosio D. Iron oxide-gold core-shell nanoparticles as multimodal imaging contrast agent. IEEE Sensors J. 2013, 13:2341-2347.
88. Schlemmer H.-P., Pichler B., Wienhard K., Schmand M., Nahmias C., Townsend D., Heiss W.-D., Claussen C. Simultaneous MR/PET for brain imaging: first patient scans. Society of Nuclear Medicine Annual Meeting Abstracts, Soc Nuclear Med 2007, 45P.
89. Cherry S.R., Louie A.Y., Jacobs R.E. The integration of positron emission tomography with magnetic resonance imaging. Proc. IEEE 2008, 96:416-438.
90. Wen S., Li K., Cai H., Chen Q., Shen M., Huang Y., Peng C., Hou W., Zhu M., Zhang G., Shi X. Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications. Biomaterials 2013, 34:1570-1580.
91. Bardhan R., Lal S., Joshi A., Halas N.J. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc. Chem. Res. 2011, 44:936-946.
92. Zhou Z., Zhang C., Qian Q., Ma J., Huang P., Zhang X., Pan L., Gao G., Fu H., Fu S., Song H., Zhi X., Ni J., Cui D. Folic acid-conjugated silica capped gold nanoclusters for targeted fluorescence/X-ray computed tomography imaging. J. Nanobiotechnol. 2013, 11:17.
93. Ma J., Huang P., He M. Folic acid-conjugated LaF(3):Yb, Tm@SiO(2) nanoprobes for targeting dual-modality imaging of upconversion luminescence and X-ray computed tomography. J. Phys. Chem. B 2012, 116:14062-14070.
94. Heo D.N., Yang D.H., Moon H.-J., Lee J.B., Bae M.S., Lee S.C., Lee W.J., Sun I.-C., Kwon I.K. Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials 2012, 33:856-866.
95. Shi X., Wang S.H., Lee I., Shen M., Baker J.R. Comparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells. Biopolymers 2009, 91:936-942.
96. Ashokan A., Menon D., Nair S., Koyakutty M. A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent. Biomaterials 2010, 31:2606-2616.
97. Elsinga P.H. Radiopharmaceutical chemistry for positron emission tomography. Methods 2002, 27:208-217.
98. Wadas T.J., Wong E.H., Weisman G.R., Anderson C.J. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem. Rev. 2010, 110:2858-2902.
99. Anderson C.J., Welch M.J. Radiometal-labeled agents (non-technetium) for diagnostic imaging. Chem. Rev. 1999, 99:2219-2234.
100. Frangioni J.V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 2003, 7:626-634.
101. Sevick-Muraca E.M., Houston J.P., Gurfinkel M. Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr. Opin. Chem. Biol. 2002, 6:642-650.
102. Thorp-Greenwood F.L., Coogan M.P. Multimodal radio-(PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents. Dalton Trans. 2011, 40:6129-6143.
103. Cai W., Chen X. Multimodality molecular imaging of tumor angiogenesis. J. Nucl. Med. 2008, 49:113S-128S.
104. Cai W., Chen K., Li Z.-B., Gambhir S.S., Chen X. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J. Nucl. Med. 2007, 48:1862-1870.
105. Liu S., Lin T.P., Li D., Leamer L., Shan H., Li Z., Gabbai F.P., Conti P.S. Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging. Theranostics 2013, 3:181-189.
106. Zhu L., Guo N., Li Q., Ma Y., Jacboson O., Lee S., Choi H.S., Mansfield J.R., Niu G., Chen X. Dynamic PET and optical imaging and compartment modeling using a dual-labeled cyclic RGD peptide probe. Theranostics 2012, 2:746-756.
107. Houston J.P., Ke S., Sevick-Muraca E.M., Wang W., Li C. Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe. J. Biomed. Opt. 2005, 10. (054010-054010-054011).
108. Li C., Wang W., Wu Q., Ke S., Houston J., Sevick-Muraca E., Dong L., Chow D., Charnsangavej C., Gelovani J.G. Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl. Med. Biol. 2006, 33:349-358.
109. Wang W., Ke S., Kwon S., Yallampalli S., Cameron A.G., Adams K.E., Mawad M.E., Sevick-Muraca E.M. A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain. Bioconjug. Chem. 2007, 18:397-402.
110. Paudyal P., Paudyal B., Iida Y., Oriuchi N., Hanaoka H., Tominaga H., Ishikita T., Yoshioka H., Higuchi T., Endo K. Dual functional molecular imaging probe targeting CD20 with PET and optical imaging. Oncol. Rep. 2009, 22:115-119.
111. Zhang Y., Hong H., Engle J.W., Yang Y., Theuer C.P., Barnhart T.E., Cai W. Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody. Mol. Pharm. 2012, 9:645-653.
112. Liang M., Liu X., Cheng D., Liu G., Dou S., Wang Y., Rusckowski M., Hnatowich D.J. Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle. Bioconjug. Chem. 2010, 21:1385-1388.
113. Nahrendorf M., Keliher E., Marinelli B., Waterman P., Feruglio P.F., Fexon L., Pivovarov M., Swirski F.K., Pittet M.J., Vinegoni C., Weissleder R. Hybrid PET-optical imaging using targeted probes. Proc. Natl. Acad. Sci. 2010, 107:7910-7915.
114. Chen K., Li Z.-B., Wang H., Cai W., Chen X. Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:2235-2244.
115. Sampath L., Wang W., Sevick-Muraca E.M. Near infrared fluorescent optical imaging for nodal staging. J. Biomed. Opt. 2008, 13:041312.
116. Sampath L., Kwon S., Ke S., Wang W., Schiff R., Mawad M.E., Sevick-Muraca E.M. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J. Nucl. Med. 2007, 48:1501-1510.
117. Xu H., Baidoo K., Gunn A.J., Boswell C.A., Milenic D.E., Choyke P.L., Brechbiel M.W. Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging. J. Med. Chem. 2007, 50:4759-4765.
118. Cohen R., Vugts D.J., Stigter-van Walsum M., Visser G.W., van Dongen G.A. Inert coupling of IRDye800CW and zirconium-89 to monoclonal antibodies for single- or dual-mode fluorescence and PET imaging. Nat. Protoc. 2013, 8:1010-1018.
119. Hong H., Zhang Y., Severin G.W., Yang Y., Engle J.W., Niu G., Nickles R.J., Chen X., Leigh B.R., Barnhart T.E., Cai W. Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW. Mol. Pharm. 2012, 9:2339-2349.
120. Hall M.A., Pinkston K.L., Wilganowski N., Robinson H., Ghosh P., Azhdarinia A., Vazquez-Arreguin K., Kolonin A.M., Harvey B.R., Sevick-Muraca E.M. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF. J. Nucl. Med. 2012, 53:1427-1437.
121. Ghosh S.C., Ghosh P., Wilganowski N., Robinson H., Hall M.A., Dickinson G., Pinkston K.L., Harvey B.R., Sevick-Muraca E.M., Azhdarinia A. Multimodal chelation platform for near-infrared fluorescence/nuclear imaging. J. Med. Chem. 2012, 56:406-416.
122. Qin Z., Hall D.J., Liss M.A., Hoh C.K., Kane C.J., Wallace A.M., Vera D.R. Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes. J. Biomed. Opt. 2013, 18:101315.
123. Zhang Y., Xiao L., Popovic K., Xie X.Z., Chordia M.D., Chung L.W.K., Williams M.B., Yue W., Pan D.F. Novel cancer-targeting SPECT/NIRF dual-modality imaging probe Tc-99m-PC-1007: synthesis and biological evaluation. Bioorg. Med. Chem. Lett. 2013, 23:6350-6354.
124. Yan X., Zhou Y., Liu S. Optical imaging of tumors with copper-labeled rhodamine derivatives by targeting mitochondria. Theranostics 2012, 2:988-998.
125. Harvey C.J., Blomley M.J., Eckersley R.J., Cosgrove D.O. Developments in ultrasound contrast media. Eur. Radiol. 2001, 11:675-689.
126. Kiessling F., Fokong S., Bzyl J., Lederle W., Palmowski M., Lammers T. Recent advances in molecular, multimodal and theranostic ultrasound imaging. Advanced Drug Delivery Reviews 2014, 72:15-27.
127. Lee H.J., Liu Y., Zhao J., Zhou M., Bouchard R.R., Mitcham T., Wallace M., Stafford R.J., Li C., Gupta S., Melancon M.P. In vitro and in vivo mapping of drug release after laser ablation thermal therapy with doxorubicin-loaded hollow gold nanoshells using fluorescence and photoacoustic imaging. J. Control. Release 2013, 172:152-158.
128. Lu W., Huang Q., Ku G., Wen X., Zhou M., Guzatov D., Brecht P., Su R., Oraevsky A., Wang L.V., Li C. Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres. Biomaterials 2010, 31:2617-2626.
129. Yang H.-W., Liu H.-L., Li M.-L., Hsi I.W., Fan C.-T., Huang C.-Y., Lu Y.-J., Hua M.-Y., Chou H.-Y., Liaw J.-W., Ma C.-C.M., Wei K.-C. Magnetic gold-nanorod/PNIPAAmMA nanoparticles for dual magnetic resonance and photoacoustic imaging and targeted photothermal therapy. Biomaterials 2013, 34:5651-5660.
130. Sheng Z., Song L., Zheng J., Hu D., He M., Zheng M., Gao G., Gong P., Zhang P., Ma Y., Cai L. Protein-assisted fabrication of nano-reduced graphene oxide for combined in vivo photoacoustic imaging and photothermal therapy. Biomaterials 2013, 34:5236-5243.
131. de la Zerda A., Bodapati S., Teed R., May S.Y., Tabakman S.M., Liu Z., Khuri-Yakub B.T., Chen X., Dai H., Gambhir S.S. Family of enhanced photoacoustic imaging agents for high-sensitivity and multiplexing studies in living mice. ACS Nano 2012, 6:4694-4701.
132. Zerda A.d.l., Liu Z., Bodapati S., Teed R., Vaithilingam S., Khuri-Yakub B.T., Chen X., Dai H., Gambhir S.S. Ultrahigh sensitivity carbon nanotube agents for photoacoustic molecular imaging in living mice. Nano Lett. 2010, 10:2168-2172.
133. Mallidi S., Larson T., Tam J., Joshi P.P., Karpiouk A., Sokolov K., Emelianov S. Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer. Nano Lett. 2009, 9:2825-2831.
134. De La Zerda A., Zavaleta C., Keren S., Vaithilingam S., Bodapati S., Liu Z., Levi J., Smith B.R., Ma T.-J., Oralkan O., Cheng Z., Chen X., Dai H., Khuri-Yakub B.T., Gambhir S.S. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat. Nanotechnol. 2008, 3:557-562.
135. Dragulescu-Andrasi A., Kothapalli S.-R., Tikhomirov G.A., Rao J., Gambhir S.S. Activatable oligomerizable imaging agents for photoacoustic imaging of furin-like activity in living subjects. J. Am. Chem. Soc. 2013, 135:11015-11022.
136. Kircher M.F., de la Zerda A., Jokerst J.V., Zavaleta C.L., Kempen P.J., Mittra E., Pitter K., Huang R., Campos C., Habte F., Sinclair R., Brennan C.W., Mellinghoff I.K., Holland E.C., Gambhir S.S. A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat. Med. 2012, 18:829-834.
137. Qin C., Cheng K., Chen K., Hu X., Liu Y., Lan X., Zhang Y., Liu H., Xu Y., Bu L., Su X., Zhu X., Meng S., Cheng Z. Tyrosinase as a multifunctional reporter gene for photoacoustic/MRI/PET triple modality molecular imaging. Sci. Rep. 2013, 3.
138. Liao A.-H., Wu S.-Y., Wang H.-E., Weng C.-H., Wu M.-F., Li P.-C. Evaluation of 18F-labeled targeted perfluorocarbon-filled albumin microbubbles as a probe for microUS and microPET in tumor-bearing mice. Ultrasonics 2013, 53:320-327.
139. 3 and tenascin-C proteins. Biomaterials 2011, 32:1130-1138.
140. 3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis. J. Nucl. Med. 2013, 54:96-103.
141. 4:Yb/Tm upconversion nanoparticles for in vivo trimodal bioimaging. Anal. Chem. 2013, 85:12166-12172.